Article

Fat Chemistry

Health Commentary with Dr. Mike Magee: a quick history of trans-fats. More information at HealthCommentary.org.

Health Commentary with Dr. Mike Magee: a quick history of trans-fats. More information at HealthCommentary.org.

Related Videos
Jennifer Flemming, MD | Credit: AASLD
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Related Content
Seonkyeong Yang, PhD I Credit: University of Florida
January 15th 2025

Anti-CGRP mAbs Are Not Linked to Increased CVD Risk in Adults with Migraine

Chelsie Derman
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Leveling Up: Cell Therapy Research Expands Horizons in Autoimmune Disease | Credit: HCPLive.com
December 31st 2024

Leveling Up: Cell Therapy Research Expands Horizons in Autoimmune Disease

Victoria Johnson Noah Stansfield
Diabetes Dialogue: Insights on INHALE-1 and CATALYST Trials | Image Credit: HCPLive
January 2nd 2025

Diabetes Dialogue: Insights on INHALE-1 and CATALYST Trials

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
5 FDA Decision to Watch for Q1 2025 | Credit: HCPLive.com
December 26th 2024

5 FDA Decisions to Watch in Q1 2025

Patrick Campbell
Richard B. Lipton, MD I Credit: Albert Einstein College of Medicine
December 24th 2024

Atogepant 60 mg Demonstrates Superior to Placebo for Migraine by Day 1

Chelsie Derman
© 2025 MJH Life Sciences

All rights reserved.